Houston [US], May 30 (ANI): According to the University of Texas MD Anderson Cancer Center, researchers have developed an ultrasound-guided cancer immunotherapy platform that promotes systemic antitumor immunity and increases immune checkpoint blockade therapeutic efficacy.
\
\
